Emerging recombinant human immunodeficiency viruses: Uneven representation of the envelope V3 region

AIDS

Volumn 13, Issue 13, 1999, Pages 1613-1621

  Renjifo, Boris ^a   Gilbert, Peter ^b   Chaplin, Beth ^a   Vannberg, Fredrik ^a   Mwakagile, Davis ^c   Msamanga, Gernard ^c   Hunter, David ^b   Fawzi, Wafaie ^b   Essex, Max ^a  

^a Harvard AIDS Institute   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MUHIMBILI MEDICAL CENTRE   (Tanzania)

Author keywords

env; gag; Genetic subtypes; HIV 1; Perinatal; Recombination; Transmission; V3 region

Indexed keywords

GAG PROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE SEQUENCE; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; TANZANIA; VIRUS RECOMBINANT; VIRUS TRANSMISSION;

AMINO ACID SEQUENCE; DISEASE TRANSMISSION, VERTICAL; GENOME; HIV CORE PROTEIN P24; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; TANZANIA;

EID: 0033390709     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199909100-00003     Document Type: Article

References (45)

1. Louwagie J, McCutchan FE, Peeters M, et al. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes, AIDS 1993, 7:769-780.
2. Louwagie J, Janssens W, Mascola J, et al. Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol 1995, 69:263-271.
3. Myers, G, Korber B, Foley B, Jeang K-T, Mellors JW, Wain-Hobson S. Human Retroviruses and AIDS, 1997: a Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos, New Mexico: Los Alamos National Laboratory; 1997.
4. Stanecki KA, Way PO. The dynamics of the HIV/AIDS pandemic. In AIDS in the World II. Edited by Mann J, Tarantola D. London: Oxford University Press; 1996:41-56.
5. Janssens W, Buve A. Nkengasong JN. The puzzle of HIV-1 sub-types in Africa, AIDS 1997, 11:705-712.
6. The Working Group on Mother-To-Child Transmission of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. J Acquir Immune Defic Synder Hum Retrovirol 1995, 8:506-510.
7. Albert J, Gaines H, Sonnerborg A, et al. Isolation of human immunodeficiency virus (HIV) from plasma during primary HIV infection. J Med Virol 1987, 23:67-73.
8. Anderson RM, Medley, GF: Epidemiology of HIV infection and AIDS: incubation and infectious periods, survival and vertical transmission. AIDS 1988, 2(suppl 1): S57-S63.
9. Blanche S, Rouzioux C, Mascato ML, et al. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaboratíve Study Group. N Engl J Med 1989, 320:1643-1648.
10. The European Collaborative Study. Mother-to-child transmission of HIV infection, Lancet 1988, ii:1039-1043.
11. Goedert JJ, Duliege AM, Amos CI, Felton S, Biggar RJ. High risk of HIV-1 infection for first-born twins. The International Registry of HIV-exposed Twins. Lancet 1991, 338:1471-1475.
12. Hira SK, Kamanga J, Bhat GJ, et al. Perinatal transmission of HIV-1 in Zambia. BMJ 1989, 299:1250-1252.
13. Lallemant M, Baillou A, Lallemant-Le Coeur S, et al. Maternal antibody response at delivery and perinatal transmission of human immunodeficiency virus type 1 in African women. Lancet 1994, 343:1001-1005.
14. Rossi P, Moschese V, Broliden PA, et al. Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers. Proc Natl Acad Sci USA 1989, 86:8055-8058.
15. Wolinsky SM, Wike CM, Korber BT, et al. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992, 255:1134-1137.
16. Mulder-Kampinga GA, Kuiken C, Dekker J, Scherpbier HJ, Boer K, Goudsmit J. Genomic human immunodeficiency virus type 1 RNA variation in mother and child following intra-uterine virus transmission. J Gen Virol 1993, 74:1747-1756.
17. Ahmad N, Baroudy BM, Baker RC, Chappey C. Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J Virol 1995, 69:1001-1012.
18. Mulder-Kampinga GA, Simonon A, Kuiken CL, et al. Similarity in env and gag genes between genomic RNAs of human immunodeficiency virus type 1 (HIV-1) from mother and infant is unrelated to time of HIV-1 RNA positivity in the child. J Virol 1995, 69:2285-2296.
19. Scarlatti G, Leitner I, Halapi E, et al. Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers. Proc Natl Acad Sci USA 1993, 90:1721-1725.
20. Munoz-Fernandez MA, Navarro J, Obregon E, et al. Immunological and virological markers of disease progression in HIV-infected children. Acta Paediatr, Suppl 1997 421:46-51.
21. Spencer LT, Ogino MT, Dankner WM, Spector SA. Clinical significance of human immunodeficiency virus type 1 pheno-types in infected children. J Infect Dis 1994, 169:491-495.
22. De Rossi A, Pasti M, Mammano F, Ometto L, Giaquinto C, Chieco-Bianchi L. Perinatal infection by human immunodeficiency virus type 1 (HIV-1): relationship between proviral copy number in vivo, viral properties in vitro, and clinical outcome. J Med Virol 1991, 35:283-289.
23. Robertson DL, Hahn BH, Sharp PM. Recombination in AIDS viruses. J Mol Evol 1995, 40:249-259.
24. McCutchan FE, Salminen MO, Carr JK, Burke DS. HIV-1 genetic diversity. AIDS 1996, 10(suppl 3):S13-S20.
25. Robertson DL, Sharp PM, McCutchan FE, Hahn BH. Recombination in HIV-1. Nature 1995, 374:124-126.
26. Weniger BG, Takebe Y, Ou CY, Yamazaki S. The molecular epidemiology of HIV in Asia. AIDS 1994, 8(suppl 2):S13-S28.
27. Renjifo B, Chaplin B, Mwakagile D, et al. Epidemic expansion of HIV type 1 subtype C and recombinant genotypes in Tanzania. AIDS Res Hum Retroviruses 1998, 14:635-638.
28. Fawzi WW, Msamanga GI, Spiegelman D, et al. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 1998, 351:1477-1482.
29. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl Acids Res 1994, 22:4673-4680.
30. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987, 4:406-425.
31. Siepel AC, Halpern AL, Macken C, Korber BT. A computer program designed to screen rapidly for HIV type 1 intersubtype recombinant sequences. AIDS Res Hum Retroviruses 1995, 11:1413-1416.
32. Korber BT, Kunstman KJ, Patterson BK, et al. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 1994, 68:7467-7481.
33. Blackard J, Renjifo B, Mwakagile D, Montana M, Fawzi W, Essex M. Transmission of HIV-1 viruses with intersubtype recombinant LTR sequences. Virology, 1999, 254:220-225
34. De Rossi A, Ometto L, Masiero S, Zanchetta M, Chieco-Bianchi L. Viral phenotype in mother-to-child HIV-1 transmission and disease progression of vertically acquired HIV-1 infection. Acta Paediatr, Suppl 1997 421:22-28.
35. Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, Ho DD. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993, 261:1179-1181.
36. Ganeshan S, Dickover RE, Korber, BT, Bryson YJ, Wolinsky SM. Human immunodefeciency virus type 1 genetic evolution in children with different rates of development of disease. J Virol 1997, 71:663-677.
37. Deng H, Liu R, Ellmeier W, et al. Identification of a major coreceptor for primary isolates of HIV-1. Nature 1996, 381:661-666.
38. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G. protein-coupled receptor. Science 1996, 272:872-877.
39. Tscherning C, Alaeus A, Fredriksson R, et al. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 1998, 24:181-188.
40. Smyth RJ, Yi Y, Singh A, Collman RG. Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate. J Virol 1998, 72:4478-4484.
41. Wang WK, Dudek T, Zhao YJ, Brumblay HG, Essex M, Lee TH. CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120. Proc Natl Acad Sci USA 1998, 95:5740-5745.
42. Speck RF, Wehrly K, Platt EJ, et al. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J Virol 1998, 71:7136-7139.
43. Korber BT, MacInnes K, Smith RF, Myers G. Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1. J Virol 1994, 68:6730-6744.
44. Zhang IQ, MacKenzie P, Cleland A, Holmes EC, Brown AJ, Simmonds P. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol 1993, 67:3345-3356.
45. Chesebro B, Wehrly K, Nishio J, et al. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol 1992, 66:6547-6554.